Pancreatic Cancer Research Consortium:
Investigation of K-ras Effector Pathways in Pancreatic Cancer
Tyler Jacks, Ph.D.
David H. Koch Professor
Director, Koch Institute for Integrative Cancer Research
Investigator, Howard Hughes Medical Institute
Collaborating PCRC Member Institution
Cold Spring Harbor Laboratory
This project seeks to study a therapy targeting the K-ras gene pathway. K-ras is the most commonly mutated gene in pancreatic cancer.
back to PCRC